Found: 4
Select item for more details and to access through your institution.
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
- Published in:
- Oncogene, 2010, v. 29, n. 11, p. 1681, doi. 10.1038/onc.2009.454
- By:
- Publication type:
- Article
p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.
- Published in:
- Clinical & Translational Oncology, 2014, v. 16, n. 6, p. 529, doi. 10.1007/s12094-013-1112-3
- By:
- Publication type:
- Article
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
- Published in:
- Oncogene, 2006, v. 25, n. 23, p. 3335, doi. 10.1038/sj.onc.1209364
- By:
- Publication type:
- Article
FK506 sensitizes mammalian cells to high osmolarity by modulating p38 MAP kinase activation.
- Published in:
- Cellular & Molecular Life Sciences, 2004, v. 61, n. 6, p. 700, doi. 10.1007/s00018-003-3388-x
- By:
- Publication type:
- Article